Results 141 to 150 of about 6,793 (233)

Updates on lung neuroendocrine neoplasm classification [PDF]

, 2023
Papotti, Mauro, Righi, Luisella, Volante, Marco   +2 more
core   +1 more source

P2.12-23 Radiological Features of SCLC-Like and NSCLC-Like Large Cell Neuroendocrine Carcinoma (LCNEC) [PDF]

, 2019
B.C.M. Hermans, Jules L. Derks, Hester A. Gietema, Esther van den Broek, E.J.M. Speel, Anne‐Marie C. Dingemans   +5 more
openalex   +1 more source

RESECTION OF HIGH-GRADE LARGE CELL NEUROENDOCRINE CARCINOMA OF THE LUNG (LCNEC): CHALLENGES IN POST-OPERATIVE MANAGEMENT OF A SOLITARY LUNG NODULE [PDF]

, 2023
MAHRUKH KHAN, Vishakha Sirpal, ANOSH A KHAN, Farah Heis, Sharon Weiner   +4 more
openalex   +1 more source

A case of combined large cell neuroendocrine carcinoma (LCNEC) and adenocarcinoma

The Journal of the Japanese Associtation for Chest Surgery, 2005
Naruyuki Kobayashi, Shigeki Kinoshita, Toshiyuki Dohi   +2 more
openaire   +2 more sources

Prostatic Metastasis of Pulmonary Large Cell Neuroendocrine Carcinoma

Journal of Cancer, 2012
Lung cancer metastases to the prostate are uncommon, and are usually found incidentally during autopsy. This case report describes a 77-year-old man with a large cell neuroendocrine carcinoma (LCNEC) of the lung and metastases from this primary cancer in
Kumi Shimizu, Taichiro Goto, Arafumi Maeshima, Yoshitaka Oyamada, Ryoichi Kato
doaj  

A Resected Case of Large-Cell Neuroendocrine Carcinoma(LCNEC) with Elevated Level of Pro-Gastrin-Releasing Peptide(31-98).

, 1995
Takashi Shibusa, Noriharu Shijubo, Masahiko Yamagishi, Yuji Morita, Shosaku Abe, Masaaki Satoh   +5 more
openalex   +2 more sources

Prognostic significance of YAP1 expression and its association with neuroendocrine markers in resected pulmonary large cell neuroendocrine carcinoma (LCNEC)

, 2022
Xujie Sun, Jinyao Zhang, Jiyan Dong, Li Liu, Xue Li, Puyuan Xing, Jianming Ying, Yi‐Qun Che, Junling Li, Lin Yang   +9 more
openalex   +1 more source

Optimal Treatment Strategies for Pulmonary Large Cell Neuroendocrine Carcinoma Based on Molecular Subtypes. [PDF]

J Clin Med
Yücel H, Kuş T, Cangi S, Aktaş G.
europepmc   +1 more source

Examining the effectiveness of follow-up chemotherapy in large cell neuroendocrine carcinoma: special emphasis on stage T1-2N0M0 according to 9^th edition TNM guidelines. [PDF]

Transl Cancer Res
Pan H, Zhang Y, Ying M, Zhai C.
europepmc   +1 more source

First-line immune checkpoint inhibitors combined with chemotherapy in advanced large-cell neuroendocrine carcinoma of the lung: a real-world retrospective study. [PDF]

Front Oncol
Ji B, Luan W, Sha R, Li W.
europepmc   +1 more source